Related Experiment Videos
[Reocclusion following successful thrombolytic therapy in acute myocardial infarct]
Insights
Reocclusion after acute myocardial infarction treatment is common, affecting 5.5% early and 25% by six months. Most patients with reocclusion experienced clinical reinfarction.
Area of Science:
- Cardiology
- Interventional Cardiology
Context:
- Acute myocardial infarction (AMI) management aims for successful reperfusion.
- Reocclusion of the treated coronary artery is a significant post-intervention complication.
- Existing literature reports reocclusion rates between 10-30%.
Purpose:
- To assess the incidence and clinical significance of coronary artery reocclusion after thrombolysis in AMI patients.
- To evaluate reocclusion rates at early (3-day) and late (6-month) follow-up stages.
- To correlate reocclusion with clinical reinfarction events.
Summary:
- This study followed 130 acute myocardial infarction patients who received successful intracoronary streptokinase thrombolysis.
- Follow-up angiography at 3 days and 6 months revealed reocclusion in 5.5% and 25.0% of patients, respectively.
- Over 75% of patients with reoccluded arteries showed clinical signs of reinfarction during follow-up.
Impact:
- Highlights the persistent risk of reocclusion and subsequent reinfarction after initial successful reperfusion therapy for AMI.
- Underscores the need for strategies to prevent or manage late reocclusion.
- Provides crucial data on reocclusion rates in patients not undergoing percutaneous coronary intervention or bypass surgery post-thrombolysis.
Abstract:
Following successful reperfusion of the previously occluded coronary artery in acute myocardial infarction, reocclusion remains an at least partially unsolved problem. The literature reports figures between 10 and 30%. In the present study, 130 out of 543 patients with successful thrombolysis by means of intracoronary streptokinase underwent a follow-up angiography at the 3rd day (106/130, 80%) and/or 6 months (76/130, 59%) after the acute intervention. During the observation period, neither PTCA nor bypass surgery were performed. Reocclusion could be documented in 5.5% of patients at the early stage, and in 25.0% half a year later. In more than 75% of patients, who presented with a reoccluded infarct related artery, clinical evidence of reinfarction had been recorded during the follow-up period.